Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Aguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, Kesavalu L, Wronski TJ.

J Bone Miner Res. 2012 Oct;27(10):2130-43. doi: 10.1002/jbmr.1669.

2.

Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model.

de Molon RS, Cheong S, Bezouglaia O, Dry SM, Pirih F, Cirelli JA, Aghaloo TL, Tetradis S.

Bone. 2014 Nov;68:11-9. doi: 10.1016/j.bone.2014.07.027. Epub 2014 Aug 2.

3.

Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.

Hokugo A, Christensen R, Chung EM, Sung EC, Felsenfeld AL, Sayre JW, Garrett N, Adams JS, Nishimura I.

J Bone Miner Res. 2010 Jun;25(6):1337-49. doi: 10.1002/jbmr.23.

4.

Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.

Takaoka K, Yamamura M, Nishioka T, Abe T, Tamaoka J, Segawa E, Shinohara M, Ueda H, Kishimoto H, Urade M.

PLoS One. 2015 Dec 14;10(12):e0144355. doi: 10.1371/journal.pone.0144355. eCollection 2015.

5.

OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.

de Molon RS, Shimamoto H, Bezouglaia O, Pirih FQ, Dry SM, Kostenuik P, Boyce RW, Dwyer D, Aghaloo TL, Tetradis S.

J Bone Miner Res. 2015 Sep;30(9):1627-40. doi: 10.1002/jbmr.2490. Epub 2015 May 27.

6.

Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.

de Molon RS, Hsu C, Bezouglaia O, Dry SM, Pirih FQ, Soundia A, Cunha FQ, Cirelli JA, Aghaloo TL, Tetradis S.

J Bone Miner Res. 2016 Aug;31(8):1596-607. doi: 10.1002/jbmr.2827. Epub 2016 May 4.

7.

Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.

Barba-Recreo P, Del Castillo Pardo de Vera JL, García-Arranz M, Yébenes L, Burgueño M.

J Craniomaxillofac Surg. 2014 Sep;42(6):744-50. doi: 10.1016/j.jcms.2013.11.005. Epub 2013 Nov 15.

PMID:
24342733
8.

Mandibular necrosis in beagle dogs treated with bisphosphonates.

Burr DB, Allen MR.

Orthod Craniofac Res. 2009 Aug;12(3):221-8. doi: 10.1111/j.1601-6343.2009.01456.x.

9.

Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S.

J Bone Miner Res. 2013 Jul;28(7):1631-40. doi: 10.1002/jbmr.1894.

10.

Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Ersan N, van Ruijven LJ, Bronckers AL, Olgaç V, Ilgüy D, Everts V.

Dentomaxillofac Radiol. 2014;43(1):20130144. doi: 10.1259/dmfr.20130144. Epub 2013 Oct 29.

11.

Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.

Kuroshima S, Yamashita J.

Bone. 2013 Sep;56(1):101-9. doi: 10.1016/j.bone.2013.05.013. Epub 2013 May 28.

PMID:
23727433
12.

Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.

Abtahi J, Agholme F, Sandberg O, Aspenberg P.

J Oral Pathol Med. 2012 Jul;41(6):494-9. doi: 10.1111/j.1600-0714.2011.01125.x. Epub 2012 Jan 23.

PMID:
22268631
13.

Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.

Williams DW, Lee C, Kim T, Yagita H, Wu H, Park S, Yang P, Liu H, Shi S, Shin KH, Kang MK, Park NH, Kim RH.

Am J Pathol. 2014 Nov;184(11):3084-93. doi: 10.1016/j.ajpath.2014.07.010. Epub 2014 Aug 28.

14.

Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.

Park S, Kanayama K, Kaur K, Tseng HC, Banankhah S, Quje DT, Sayre JW, Jewett A, Nishimura I.

J Biol Chem. 2015 Jul 10;290(28):17349-66. doi: 10.1074/jbc.M115.652305. Epub 2015 May 26.

15.

Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease.

Kim JW, Tatad JC, Landayan ME, Kim SJ, Kim MR.

Bone. 2015 Dec;81:442-8. doi: 10.1016/j.bone.2015.08.012. Epub 2015 Aug 19.

PMID:
26297440
16.

Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats.

Tsurushima H, Kokuryo S, Sakaguchi O, Tanaka J, Tominaga K.

Int J Oral Maxillofac Surg. 2013 Nov;42(11):1481-7. doi: 10.1016/j.ijom.2013.06.011. Epub 2013 Aug 6.

PMID:
23932020
17.
18.

Zoledronate induces osteonecrosis of the jaw in sheep.

Voss PJ, Stoddart M, Ziebart T, Zeiter S, Nelson K, Bittermann G, Schmelzeisen R, Poxleitner P.

J Craniomaxillofac Surg. 2015 Sep;43(7):1133-8. doi: 10.1016/j.jcms.2015.04.020. Epub 2015 Apr 30.

PMID:
26154396
19.

Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.

Allen MR, Chu TM, Ruggiero SL.

J Oral Maxillofac Surg. 2013 Jun;71(6):1017-26. doi: 10.1016/j.joms.2012.11.016. Epub 2013 Feb 1.

20.

Zoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient mice.

Bonnet N, Lesclous P, Saffar JL, Ferrari S.

PLoS One. 2013;8(3):e58726. doi: 10.1371/journal.pone.0058726. Epub 2013 Mar 7.

Supplemental Content

Support Center